Cargando…
Metabolic signatures of human breast cancer
Metabolomics has emerged as a new discovery tool with the promise of identifying therapeutic targets in cancer. Recent discoveries have described essential metabolomic pathways in breast cancer and characterized oncometabolites that drive tumor growth and progression. Oncogenes like MYC and tumor su...
Autores principales: | Mishra, Prachi, Ambs, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438683/ https://www.ncbi.nlm.nih.gov/pubmed/26005711 http://dx.doi.org/10.4161/23723556.2014.992217 |
Ejemplares similares
-
ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
por: Mishra, Prachi, et al.
Publicado: (2018) -
Metabolic Profiles are Principally Different between Cancers of the Liver, Pancreas and Breast
por: Budhu, Anuradha, et al.
Publicado: (2014) -
Prognostic Significance of Subtype Classification for Short- and Long-Term Survival in Breast Cancer: Survival Time Holds the Key
por: Ambs, Stefan
Publicado: (2010) -
Immune Inflammation Pathways as Therapeutic Targets to Reduce Lethal Prostate Cancer in African American Men
por: Kiely, Maeve, et al.
Publicado: (2021) -
A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype
por: Cheng, Qing, et al.
Publicado: (2014)